# Role of Amlodipine in Reduction of CIN

> **NCT07291375** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Minia University** · enrollment: 40 (estimated)

## Conditions studied

- Contrast-induced Nephropathy

## Interventions

- **DRUG:** Calcium channel blocker
- **OTHER:** Hydration

## Key facts

- **NCT ID:** NCT07291375
- **Lead sponsor:** Minia University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-20
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-07-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07291375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07291375, "Role of Amlodipine in Reduction of CIN". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07291375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*